Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2020

Pharma News, 2020

NIH to conduct studies on compound similar to remdesivir The Week
NIH to conduct studies on compound similar to remdesivir The Week
The National Institutes of Health is set to study a compound similar to remdesivir to see if it could be effective in treating COVID-19, Stat News reports.
Translate Bio, Sanofi COVID-19 vaccine candidate produces immune response in animal studies
Translate Bio, Sanofi COVID-19 vaccine candidate produces immune response in animal studies
(Reuters) - Translate Bio Inc (TBIO.
Pandemic pace slows worldwide except for southeast Asia, eastern Mediterranean: WHO
Pandemic pace slows worldwide except for southeast Asia, eastern Mediterranean: WHO
GENEVA (Reuters) - The COVID-19 pandemic is still expanding, but the rise in cases and deaths has slowed globally, except for southeast Asia and the eastern Mediterranean regions, the World He...
Metformin recalls continue as Bayshore pulls diabetes drug on carcinogen scare
Metformin recalls continue as Bayshore pulls diabetes drug on carcinogen scare
After finding high levels of a probable carcinogen in samples of the common diabetes med metformin, the FDA has scrambled to get affected lots out of consumers' hands.
Clinical research cut 87% at peak of pandemic
Clinical research cut 87% at peak of pandemic
At the peak of the COVID-19 pandemic, clinical research capacity may have been slashed by up to 87% in England, according to a new study led by UCL academics.
AstraZeneca starts trial of COVID-19 antibody treatment
AstraZeneca starts trial of COVID-19 antibody treatment
(Reuters) - British drugmaker AstraZeneca (AZN.
Mexico signs up to Italian vaccine trial for coronavirus: minister
Mexico signs up to Italian vaccine trial for coronavirus: minister
MEXICO CITY (Reuters) - Mexico is due to take part in clinical trials of an Italian vaccine being developed against the coronavirus, Foreign Minister Marcelo Ebrard said on Tuesday.
J&J strikes US$6.5 billion deal for autoimmune disease specialist Momenta
J&J strikes US$6.5 billion deal for autoimmune disease specialist Momenta
REUTERS.
BioMarin Receives Complete Response Letter (CRL) from FDA for Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A
BioMarin Receives Complete Response Letter (CRL) from FDA for Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A
SAN RAFAEL, Calif.
Merck to build £1B London R&D hub for its first ex-U.S. early research center
Merck to build £1B London R&D hub for its first ex-U.S. early research center
Making good on its 2017 promise to back post-Brexit Britain, U.
Drugmakers slash prices to win China's bulk-buy contracts: state media
Drugmakers slash prices to win China's bulk-buy contracts: state media
BEIJING/SHANGHAI (Reuters) - Drugmakers have slashed prices by up to 95% to win state contracts in China’s largest bidding round of its drug procurement programme, state media said on Th...
FDA Approves GSK’s Blenrep as Fourth-Line Multiple Myeloma Monotherapy Treatment
FDA Approves GSK’s Blenrep as Fourth-Line Multiple Myeloma Monotherapy Treatment
With its second regulatory approval in four months, GlaxoSmithKline is once again making its mark as an oncology-focused pharmaceutical company.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand